A detailed history of Cerity Partners LLC transactions in Pfizer Inc stock. As of the latest transaction made, Cerity Partners LLC holds 1,571,652 shares of PFE stock, worth $43.2 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
1,571,652
Previous 2,077,035 24.33%
Holding current value
$43.2 Million
Previous $57.6 Million 23.71%
% of portfolio
0.12%
Previous 0.15%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$25.26 - $29.6 $12.8 Million - $15 Million
-505,383 Reduced 24.33%
1,571,652 $44 Million
Q1 2024

May 14, 2024

BUY
$25.89 - $29.73 $15.7 Million - $18 Million
605,691 Added 41.17%
2,077,035 $57.6 Million
Q4 2023

Jan 26, 2024

BUY
$26.13 - $33.94 $6.23 Million - $8.1 Million
238,611 Added 19.36%
1,471,344 $42.4 Million
Q3 2023

Nov 13, 2023

SELL
$32.09 - $37.51 $9.83 Million - $11.5 Million
-306,198 Reduced 19.9%
1,232,733 $40.9 Million
Q2 2023

Aug 14, 2023

BUY
$36.12 - $41.79 $6.08 Million - $7.04 Million
168,380 Added 12.29%
1,538,931 $56.4 Million
Q1 2023

May 11, 2023

BUY
$39.39 - $51.28 $9.87 Million - $12.8 Million
250,559 Added 22.37%
1,370,551 $55.9 Million
Q4 2022

Feb 15, 2023

BUY
$41.75 - $54.5 $26.5 Million - $34.5 Million
633,897 Added 130.41%
1,119,992 $57.4 Million
Q3 2022

Nov 10, 2022

SELL
$43.76 - $53.42 $152,634 - $186,328
-3,488 Reduced 0.71%
486,095 $21.3 Million
Q2 2022

Aug 10, 2022

BUY
$46.53 - $55.17 $12.4 Million - $14.7 Million
266,486 Added 119.45%
489,583 $25.7 Million
Q1 2022

Apr 25, 2022

BUY
$45.75 - $56.69 $624,853 - $774,272
13,658 Added 6.52%
223,097 $10.9 Million
Q4 2021

Feb 14, 2022

BUY
$41.32 - $61.25 $1.83 Million - $2.71 Million
44,295 Added 26.82%
209,439 $11.7 Million
Q3 2021

Oct 25, 2021

SELL
$39.25 - $50.42 $358,627 - $460,687
-9,137 Reduced 5.24%
165,144 $7.1 Million
Q2 2021

Aug 11, 2021

SELL
$35.91 - $40.68 $23,916 - $27,092
-666 Reduced 0.38%
174,281 $6.83 Million
Q1 2021

Aug 11, 2021

SELL
$33.49 - $37.77 $1.82 Million - $2.06 Million
-54,425 Reduced 23.73%
174,947 $6.34 Million
Q1 2021

May 12, 2021

SELL
$33.49 - $37.77 $332,388 - $374,867
-9,925 Reduced 4.15%
229,372 $8.31 Million
Q4 2020

Feb 11, 2021

BUY
$33.47 - $42.56 $1.79 Million - $2.28 Million
53,463 Added 28.77%
239,297 $8.81 Million
Q3 2020

Nov 12, 2020

SELL
$31.75 - $37.25 $2.57 Million - $3.02 Million
-80,951 Reduced 30.34%
185,834 $6.82 Million
Q2 2020

Aug 14, 2020

BUY
$30.12 - $36.54 $31,445 - $38,147
1,044 Added 0.39%
266,785 $8.72 Million
Q1 2020

May 14, 2020

BUY
$27.03 - $38.62 $90,793 - $129,724
3,359 Added 1.28%
265,741 $8.67 Million
Q4 2019

Feb 14, 2020

SELL
$32.92 - $37.36 $329,200 - $373,600
-10,000 Reduced 3.67%
262,382 $10.3 Million
Q3 2019

Oct 30, 2019

BUY
$32.49 - $42.13 $19,721 - $25,572
607 Added 0.22%
272,382 $9.79 Million
Q2 2019

Aug 14, 2019

BUY
$36.98 - $41.52 $6.11 Million - $6.86 Million
165,289 Added 155.22%
271,775 $11.8 Million
Q1 2019

May 14, 2019

SELL
$37.5 - $41.2 $138,600 - $152,275
-3,696 Reduced 3.35%
106,486 $4.52 Million
Q4 2018

Feb 06, 2019

SELL
$38.47 - $43.86 $141,954 - $161,843
-3,690 Reduced 3.24%
110,182 $4.81 Million
Q3 2018

Nov 15, 2018

SELL
$34.47 - $41.81 $70,249 - $85,208
-2,038 Reduced 1.76%
113,872 $5.02 Million
Q2 2018

Aug 15, 2018

SELL
$32.98 - $35.16 $4.5 Million - $4.79 Million
-136,370 Reduced 54.06%
115,910 $4.21 Million
Q1 2018

May 15, 2018

BUY
$31.91 - $37.02 $149,179 - $173,068
4,675 Added 1.89%
252,280 $8.95 Million
Q4 2017

Feb 14, 2018

BUY
$33.26 - $35.29 $311,247 - $330,243
9,358 Added 3.93%
247,605 $8.97 Million
Q3 2017

Nov 13, 2017

BUY
$31.0 - $34.15 $7.39 Million - $8.14 Million
238,247
238,247 $8.51 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $154B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Cerity Partners LLC Portfolio

Follow Cerity Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cerity Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cerity Partners LLC with notifications on news.